News
2d
The Punch on MSNSickle cell disease and knee joint pain: Why steriods aren’t always the best optionFor people living with sickle cell disease, joint pain, especially in the knees, can be a frustrating and persistent ...
Paris: Sanofi has received orphan drug designation from the US Food and Drug Administration (FDA) for rilzabrutinib, a novel, ...
New gene therapy improves the life of 18-year-old with Sickle Cell Disease which affects 5,000 New Jersey residents living ...
Sickle Cell 5K Walk/Run is taking place Saturday, June 21 at Riverside Park on the near northwest side of Indianapolis.
Individuals with both sickle cell disease (SCD) and sickle cell trait are at higher risk than others of developing renal medullary cancer (RMC), the rarest and deadliest subtype of kidney cancer.
In addition to sickle cell disease, rilzabrutinib has received orphan drug designation for immune thrombocytopenia (ITP) in the US, the EU, and Japan, for warm autoimmune hemolytic anemia (wAIHA) in ...
At Fred Hutch Cancer Center, we care for adults with sickle cell disease. Along with our local patients, we see many people from farther away, like Alaska. They get most of their care near home, but ...
For the first time in his life, a young New Jersey man is pain-free thanks to a new gene treatment working to cure patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results